Getinge Receives EU MDR Approval for Advanta V12 Covered Stent System

Getinge has announced the recent achievement of an EU MDR certificate for the Advanta V12 covered stent system, which is indicated for the treatment of patients diagnosed with renal artery stenosis and/or Aortoiliac Occlusive Disease (AIOD), including lesions at the aortic bifurcation, when endovascular therapy is required.

Renowned for its versatility, precision, and predictability, the Advanta V12 covered stent system has met the needs of surgeons and patients for more than 20 years and is the only durable solution backed by decades of clinical and real-world evidence. This investment in regulatory excellence not only supports our growth ambitions and future endeavors, but also reinforces our commitment to making a positive impact on the lives of the patients we serve,” said Chad Carlton, Vice President of Vascular Systems at Getinge.

To view the source version, please click HERE.

en_GBEnglish (UK)